97 related articles for article (PubMed ID: 12845369)
21. Okadaic acid potentiates 3-methylcholanthrene-induced CYP2A8 gene expression in primary cultures of Syrian hamster hepatocytes: possible involvement of activator protein-1.
Tohkin M; Kurose K; Fukuhara M
Mol Pharmacol; 1996 Sep; 50(3):556-64. PubMed ID: 8794894
[TBL] [Abstract][Full Text] [Related]
22. Microarray analysis of hepatic gene expression in pyrazole-mediated hepatotoxicity: identification of potential stimuli of Cyp2a5 induction.
Nichols KD; Kirby GM
Biochem Pharmacol; 2008 Jan; 75(2):538-51. PubMed ID: 17945193
[TBL] [Abstract][Full Text] [Related]
23. Acute cadmium chloride administration induces hepatic and renal CYP2A5 mRNA, protein and activity in the mouse: involvement of transcription factor NRF2.
Abu-Bakar A; Satarug S; Marks GC; Lang MA; Moore MR
Toxicol Lett; 2004 Mar; 148(3):199-210. PubMed ID: 15041070
[TBL] [Abstract][Full Text] [Related]
24. Induction of CYP2A5 by pyrazole and its derivatives in mouse primary hepatocytes.
Kojo A; Viitala P; Pasanen M; Pelkonen O; Raunio H; Juvonen R
Arch Toxicol; 1998 May; 72(6):336-41. PubMed ID: 9657280
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the Cyp2a5 gene involves an aryl hydrocarbon receptor-dependent pathway.
Arpiainen S; Raffalli-Mathieu F; Lang MA; Pelkonen O; Hakkola J
Mol Pharmacol; 2005 Apr; 67(4):1325-33. PubMed ID: 15657367
[TBL] [Abstract][Full Text] [Related]
26. Effects of lipopolysaccharide-stimulated inflammation and pyrazole-mediated hepatocellular injury on mouse hepatic Cyp2a5 expression.
Gilmore WJ; Hartmann G; Piquette-Miller M; Marriott J; Kirby GM
Toxicology; 2003 Mar; 184(2-3):211-26. PubMed ID: 12499123
[TBL] [Abstract][Full Text] [Related]
27. Analysis of RNA-protein interactions of mouse liver cytochrome P4502A5 mRNA.
Tilloy-Ellul A; Raffalli-Mathieu F; Lang MA
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):695-703. PubMed ID: 10215609
[TBL] [Abstract][Full Text] [Related]
28. Posttranscriptional regulation of coumarin 7-hydroxylase induction by xenobiotics in mouse liver: mRNA stabilization by pyrazole.
Aida K; Negishi M
Biochemistry; 1991 Aug; 30(32):8041-5. PubMed ID: 1868078
[TBL] [Abstract][Full Text] [Related]
29. Expression of genes encoding for drug metabolising cytochrome P450 enzymes and P-glycoprotein in the rat small intestine; comparison to the liver.
Lindell M; Lang M; Lennernäs H
Eur J Drug Metab Pharmacokinet; 2003; 28(1):41-8. PubMed ID: 14503663
[TBL] [Abstract][Full Text] [Related]
30. Induction of mouse CYP2J by pyrazole in the eye, kidney, liver, lung, olfactory mucosa, and small intestine, but not in the heart.
Xie Q; Zhang QY; Zhang Y; Su T; Gu J; Kaminsky LS; Ding X
Drug Metab Dispos; 2000 Nov; 28(11):1311-6. PubMed ID: 11038158
[TBL] [Abstract][Full Text] [Related]
31. Expression of cytochrome P450 2A5 in a C57BL/6J mouse model of nonalcoholic fatty liver disease.
Li R; Guo G; Cao Y; Wang Y; Liu F; Zhang X
Pharmacology; 2013; 92(1-2):26-31. PubMed ID: 23867551
[TBL] [Abstract][Full Text] [Related]
32. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Su T; Bao Z; Zhang QY; Smith TJ; Hong JY; Ding X
Cancer Res; 2000 Sep; 60(18):5074-9. PubMed ID: 11016631
[TBL] [Abstract][Full Text] [Related]
33. Dose dependent inhibitory effects of dietary 8-methoxypsoralen on NNK-induced lung tumorigenesis in female A/J mice.
Takeuchi H; Saoo K; Matsuda Y; Yokohira M; Yamakawa K; Zeng Y; Miyazaki M; Fujieda M; Kamataki T; Imaida K
Cancer Lett; 2006 Mar; 234(2):232-8. PubMed ID: 15893417
[TBL] [Abstract][Full Text] [Related]
34. Cell localization and regulation of expression of cytochrome P450 1A1 and 2B1 in rat lung after induction with 3-methylcholanthrene using mRNA hybridization and immunohistochemistry.
Pairon JC; Trabelsi N; Buard A; Fleury-Feith J; Bachelet CM; Poron F; Beaune P; Brochard P; Laurent P
Am J Respir Cell Mol Biol; 1994 Oct; 11(4):386-96. PubMed ID: 7917307
[TBL] [Abstract][Full Text] [Related]
35. Cytochrome P450 2A isoenzymes in freshly prepared blood lymphocytes isolated from rats and validation as a biomarker for clinical studies in humans.
Sharma A; Dinesh K; Yadav S; Jain SK; Pant MC; Parmar D
Xenobiotica; 2013 Apr; 43(4):311-9. PubMed ID: 22934830
[TBL] [Abstract][Full Text] [Related]
36. Induction of rat small intestinal cytochrome P-450 2J4.
Zhang QY; Ding X; Dunbar D; Cao L; Kaminsky LS
Drug Metab Dispos; 1999 Oct; 27(10):1123-7. PubMed ID: 10497137
[TBL] [Abstract][Full Text] [Related]
37. Cytochrome P450 2C11 5'-flanking region and promoter mediate in vivo suppression by 3-methylcholanthrene.
Sawaya RM; Riddick DS
Drug Metab Dispos; 2008 Sep; 36(9):1803-11. PubMed ID: 18524872
[TBL] [Abstract][Full Text] [Related]
38. Acute sodium arsenite treatment induces Cyp2a5 but not Cyp1a1 in the C57Bl/6 mouse in a tissue (kidney) selective manner.
Seubert JM; Webb CD; Bend JR
J Biochem Mol Toxicol; 2002; 16(2):96-106. PubMed ID: 11979426
[TBL] [Abstract][Full Text] [Related]
39. Cytochrome P450 species involved in the metabolism of quinoline.
Reigh G; McMahon H; Ishizaki M; Ohara T; Shimane K; Esumi Y; Green C; Tyson C; Ninomiya S
Carcinogenesis; 1996 Sep; 17(9):1989-96. PubMed ID: 8824525
[TBL] [Abstract][Full Text] [Related]
40. Characterization of cytochrome P450 expression in human oesophageal mucosa.
Lechevrel M; Casson AG; Wolf CR; Hardie LJ; Flinterman MB; Montesano R; Wild CP
Carcinogenesis; 1999 Feb; 20(2):243-8. PubMed ID: 10069460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
